• Abdallah AA, Krige JE, Bornman PC 2007 Biliary tract obstruction in chronic pancreatitis. HPB (Oxford) 9: 421-428. *

• Abraham SC, Cruz-Correa M, Argani P, Furth EE, Hruban RH, Boitnott JK 2003 Lymphoplasmacytic chronic cholecystitis and biliary tract disease in patients with lymphoplasmacytic sclerosing pancreatitis. Am. J. Surg. Pathol. 27: 441-451.

• Abraham SC, Wilentz RE, Yeo CJ, Sohn TA, Cameron JL, Boitnott JK, Hruban RH 2003 Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all 'chronic pancreatitis'? Am. J. Surg. Pathol. 27: 110-120.

• Adamsen S, Olsen M, Jendresen MB, Holck S, Glenthoj A 2006 Endobiliary brush biopsy: intra- and interobserver variation in cytological evaluation of brushings from bile duct strictures. Scand. J. Gastroenterol. 41: 597-603. *

• Ahmad J, Slivka A 2002 Hepatobiliary disease in inflammatory bowel disease. Gastroenterol. Clin. North Am. 31: 329-345.

• Ahrendt SA 2008 Surgical approaches to strictures in primary sclerosing cholangitis. J. Gastrointest. Surg. 12: 423-425. *

• Aizawa K, Kawaguchi S, Doi M, Mizuno W, Uragami K, Oka T, Miyamoto H, Itoh H, Nishioka S 1992 A case of primary intrahepatic sclerosing cholangitis (PISC) complicated with atypical biliary epithelial proliferation. Intern. Med. 31: 114-121. *

• Alam I, Levenson SD, Ferrell LD, Bass NM 1997 Diffuse intrahepatic biliary strictures in sarcoidosis resembling sclerosing cholangitis. Case report and review of the literature. Dig. Dis. Sci. 42: 1295-1301. *

• Alazmi WM, Fogel EL, Watkins JL, McHenry L, Tector JA, Fridell J, Mosler P, Sherman S, Lehman GA 2006 Recurrence rate of anastomotic biliary strictures in patients who have had previous successful endoscopic therapy for anastomotic narrowing after orthotopic liver transplantation. Endoscopy 38: 571-574.

• Alazmi WM, McHenry L, Watkins JL, Fogel EL, Schmidt S, Sherman S, Lehman GL 2006 Chemotherapy-induced sclerosing cholangitis: long-term response to endoscopic therapy. J. Clin. Gastroenterol. 40: 353-357.

• Alba LM, Angulo P, Lindor KD 2002 Primary sclerosing cholangitis. Minerva Gastroenterol. Dietol. 48: 99-113.

• Alexander S, Bourke MJ, Williams SJ, Bailey A, Gill A, Kench JG 2008 Diagnosis of autoimmune pancreatitis with intraductal biliary biopsy and treatment of stricture with serial placement of multiple biliary stents. Gastrointest. Endosc. 68: 396-399.

• Ang TL, Fock KM, Ng TM, Teo EK, Chua TS, Tan JY 2002 Clinical profile of primary sclerosing cholangitis in Singapore. J. Gastroenterol. Hepatol. 17: 908-913. *

• Angulo P, Lindor KD 1999 Primary biliary cirrhosis and primary sclerosing cholangitis. Clin. Liver Dis. 3: 529-570. *

• Anwar MA, Rampling MW 2004 Erythrocyte hyper-aggregation in a patient undergoing orthotopic transplantation for primary sclerosing cholangitis complicated by biliary stricture. Clin. Hemorheol. Microcirc. 31: 169-172.

• Asioli S, Accinelli G, Pacchioni D, Bussolati G 2008 Diagnosis of biliary tract lesions by histological sectioning of brush bristles as alternative to cytological smearing. Am. J. Gastroenterol. 103: 1274-1281. *

• Atar E, Bachar GN, Bartal G, Mor E, Neyman H, Graif F, Belenky A 2005 Use of peripheral cutting balloon in the management of resistant benign ureteral and biliary strictures. J. Vasc. Interv. Radiol. 16: 241-245.

• Bacchella T, Figueira ER, Makdissi FF, Rocha-Santos V, Martino RB, Andraus W, Canedo LF, Machado MA, Machado MC 2004 Biliary reconstruction without T-tube in liver transplantation. Transplant. Proc. 36: 951-952. *

• Baillie J 2008 Endoscopic therapy in acute recurrent pancreatitis. World J. Gastroenterol. 14: 1034-1037. *

• Baluyut AR, Sherman S, Lehman GA, Hoen H, Chalasani N 2001 Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis. Gastrointest. Endosc. 53: 308-312. *

• Barnes DS 2002 Intrahepatic cholestatic liver disease. http://www.clevelandclinicmeded.com/diseasemanagement/gastro/intrahepatic/intrahepatic1.htm.

• Barnett JL 2002 Endoscopic management of biliary disease. Curr. Opin. Gastroenterol. 18: 378-382.

• Baron TH, Fleischer DE 2002 Past, present, and future of endoscopic retrograde cholangiopancreatography: perspectives on the National Institutes of Health consensus conference. Mayo Clin. Proc. 77: 407-412. *

• Bartoli E, Delcenserie R, Yzet T, Brazier F, Geslin G, Regimbeau JM, Dupas JL 2005 Endoscopic treatment of chronic pancreatitis. Gastroenterol. Clin. Biol. 29: 515-521.

• Batts KP 1998 Ischemic cholangitis. Mayo Clin. Proc. 73: 380-385.

• Batts KP, Wang X 1998 Recurrence of primary biliary cirrhosis, autoimmune cholangitis and primary sclerosing cholangitis after liver transplantation. Clin. Liver Dis. 2: 421-435, xi.

• Berkmen T, Echenique A, Russell E 2001 Ultrasound guidance in accessing the afferent limb of a modified Roux-en-Y choledochojejunostomy for percutaneous dilation of biliary strictures. J. Vasc. Interv. Radiol. 12: 1219-1222. *

• Bilgin M, Balci NC, Erdogan A, Momtahen AJ, Alkaade S, Rau WS 2008 Hepatobiliary and pancreatic MRI and MRCP findings in patients with HIV infection. AJR Am. J. Roentgenol. 191: 228-232.

• Bilik R, Superina RA, Phillips J, Edwards V 1995 Prevention of biliary cirrhosis following hepatic arterial thrombosis after liver transplantation in children by using ursodeoxycholic acid. J. Pediatr. Surg. 30: 49-52.

• Bjornsson E, Chapman RW 2003 Sclerosing cholangitis. Curr. Opin. Gastroenterol. 19: 270-275.

• Bjornsson E, Lindqvist-Ottosson J, Asztely M, Olsson R 2004 Dominant strictures in patients with primary sclerosing cholangitis. Am. J. Gastroenterol. 99: 502-508. *

• Boberg KM, Jebsen P, Clausen OP, Foss A, Aabakken L, Schrumpf E 2006 Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. J. Hepatol. 45: 568-574. *

• Boberg KM, Schrumpf E 2004 Diagnosis and treatment of cholangiocarcinoma. Curr. Gastroenterol. Rep. 6: 52-59.

• Boberg KM, Schrumpf E 2003 Diagnosis and differential diagnosis of primary sclerosing cholangitis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 59-60. October 15-16. *

• Bories E, Pesenti C, Caillol F, Lopes C, Giovannini M 2007 Transgastric endoscopic ultrasonography-guided biliary drainage: results of a pilot study. Endoscopy 39: 287-291.

• Brandsaeter B, Schrumpf E, Clausen OP, Abildgaard A, Hafsahl G, Bjoro K 2004 Recurrent sclerosing cholangitis or ischemic bile duct lesions - a diagnostic challenge? Liver Transpl. 10: 1073-1074. *

• Broome U 2005 Clinical concepts in PSC. Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 76. *

• Buc E, Lesurtel M, Belghiti J 2008 Is preoperative histological diagnosis necessary before referral to major surgery for cholangiocarcinoma? HPB (Oxford) 10: 98-105. *

• Buczkowski AK, Schaeffer DF, Kim PT, Ho SG, Yoshida EM, Steinbrecher UP, Erb SR, Chung SW, Scudamore CH 2007 Spatulated end-to-end bile duct reconstruction in orthotopic liver transplantation. Clin. Transplant. 21: 7-12. *

• Buis CI, Hoekstra H, Verdonk RC, Porte RJ 2006 Causes and consequences of ischemic-type biliary lesions after liver transplantation. J. Hepatobiliary Pancreat. Surg. 13: 517-524. *

• Buis CI, Verdonk RC, Van der Jagt EJ, van der Hilst CS, Slooff MJ, Haagsma EB, Porte RJ 2007 Nonanastomotic biliary strictures after liver transplantation, part 1: radiological features and risk factors for early vs. late presentation. Liver Transpl. 13: 708-718. *

• Caldwell SH, Hespenheide EE, Harris D, de Lange EE 2001 Imaging and clinical characteristics of focal atrophy of segments 2 and 3 in primary sclerosing cholangitis. J. Gastroenterol. Hepatol. 16: 220-224. *

• Caldwell SH, Oelsner DH, Bickston SJ, Mays K, Yeaton P 1996 Intrahepatic biliary endoscopy in sclerosing cholangitis. J. Clin. Gastroenterol. 23: 152-256.

• Campbell WL, Ferris JV, Holbert BL, Thaete FL, Baron RL 1998 Biliary tract carcinoma complicating primary sclerosing cholangitis: evaluation with CT, cholangiography, US, and MR imaging. Radiology 207: 41-50. *

• Campbell WL, Sheng R, Zajko AB, Abu-Elmagd K, Demetris AJ 1994 Intrahepatic biliary strictures after liver transplantation. Radiology 191: 735-740. *

• Carpenter HA 1998 Bacterial and parasitic cholangitis. Mayo Clin. Proc. 73: 473-478.

• Chahal P, Baron TH, Poterucha JJ, Rosen CB 2007 Endoscopic retrograde cholangiography in post-orthotopic liver transplant population with Roux-en-Y biliary reconstruction. Liver Transpl. 13: 1168-1173.

• Chang JM, Lee JM, Suh KS, Yi NJ, Kim YT, Kim SH, Han JK, Choi BI 2005 Biliary complications in living donor liver transplantation: imaging findings and the roles of interventional procedures. Cardiovasc. Intervent. Radiol. 28: 756-767.

• Chapman RW 2003 Viruses, protozoans and drugs as etiological factors in primary sclerosing cholangitis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 73-74. October 15-16. *

• Chapman RW 2003 The management of primary sclerosing cholangitis. Curr. Gastroenterol. Rep. 5: 9-17.

• Charatcharoenwitthaya P, Enders FB, Halling KC, Lindor KD 2008 Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology Jun 9 [Epub ahead of print].

• Charatcharoenwitthaya P, Lindor KD 2006 Primary sclerosing cholangitis: diagnosis and management. Curr. Gastroenterol. Rep. 8: 75-82.

• Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, Zhang L, Clain JE, Pearson RK, Petersen BT, Vege SS, Farnell MB 2006 Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin. Gastroenterol. Hepatol. 4: 1010-1016.

• Chaudry G, Navarro OM, Levine DS, Oudjhane K 2006 Abdominal manifestations of cystic fibrosis in children. Pediatr. Radiol. 36: 233-240.

• Chazouilleres O 2004 Primary sclerosing cholangitis and biliary malignancy: a glimmer of hope? J. Hepatol. 40: 857-859. *

• Chen WD, Gluud C 2004 Glucocorticosteroids for primary sclerosing cholangitis. Cochrane Database Syst. Rev. 3: CD004036. *

• Cheng CL, Fogel EL, Sherman S, McHenry L, Watkins JL, Croffie JM, Gupta SK, Fitzgerald JF, Lazzell-Pannell L, Schmidt S, Lehman GA 2005 Diagnostic and therapeutic endoscopic retrograde cholangiopancreatography in children: a large series report. J. Pediatr. Gastroenterol. Nutr. 41: 445-453. *

• Choi EK, Kim MH, Kim JC, Han J, Oh SI, Jeong WJ, Jeong JY, Lee SS, Seo DW, Lee SK 2006 The long-term follow-up results after steroid treatment in patients with autoimmune chronic pancreatitis. Korean J. Gastroenterol. 47: 440-448.

• Cholongitas E, Shusang V, Papatheodoridis GV, Marelli L, Manousou P, Rolando N, Patch D, Rolles K, Davidson B, Burroughs AK 2008 Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl. 14: 138-143.

• Church NI, Pereira SP, Deheragoda MG, Sandanayake N, Amin Z, Lees WR, Gillams A, Rodriguez-Justo M, Novelli M, Seward EW, Hatfield AR, Webster GJ 2007 Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am. J. Gastroenterol. 102: 2417-2425. *

• Colle I, Van Vlierberghe H, Pattyn P, Troisi R, Vogelaers D, de Hemptinne B, De Vos M 2003 Cholestasis as presenting symptom of portal cavernoma. Hepatol. Res. 25: 32-37. *

• Collier NA, Armitage NC, Hadjis NS, Blumgart LH 1985 Surgical approaches in primary sclerosing cholangitis. Aust. N.Z.J. Surg. 55: 437-442.

• Corbani A, Burroughs AK 2008 Intrahepatic cholestasis after liver transplantation. Clin. Liver Dis. 12: 111-129.

• Corvera CU, Blumgart LH, Darvishian F, Klimstra DS, Dematteo R, Fong Y, D'Angelica M, Jarnagin WR 2005 Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma. J. Am. Coll. Surg. 201: 862-869. *

• Costamagna G, Familiari P, Tringali A, Mutignani M 2007 Multidisciplinary approach to benign biliary strictures. Curr. Treat. Options Gastroenterol. 10: 90-101.

• Cox KL, Cox KM 1998 Oral vancomycin: treatment of primary sclerosing cholangitis in children with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 27: 580-583.

• Cozart JC, Haber GB 1999 The Endocoil stent for malignant biliary obstruction. Gastrointest. Endosc. Clin. N. Am. 9: 503-512.

• Craig DA, MacCarty RL, Wiesner RH, Grambsch PM, LaRusso NF 1991 Primary sclerosing cholangitis: value of cholangiography in determining the prognosis. AJR Am. J. Roentgenol. 157: 959-964. *

• Dantas W 2000 Primary sclerosing cholangitis. Rev. Gastroenterol. Peru 20: 270-284.

• Das KM 2004 Immunopathogenesis of primary sclerosing cholangitis: possible role of a shared colonic and biliary epithelial antigen. J. Gastroenterol. Hepatol. 19: S290-S294. *

• Davies YK, Cox KM, Abdullah BA, Safta A, Terry AB, Cox KL 2008 Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic. J. Pediatr. Gastroenterol. Nutr. 47: 61-67. *

• Davies YK, Cox KM, Abdullah BA, Terry AB, Cox KL 2003 Oral vancomycin: treatment of primary sclerosing cholangitis in children. J. Pediatr. Gastroenterol. Nutr. 37: 345-346. *

• Demetris AJ 2006 Distinguishing between recurrent primary sclerosing cholangitis and chronic rejection. Liver Transpl. 12: S68-S72. *

• Demetris AJ 2006 Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 44: 489-501. *

• Demetris AJ, Fontes P, Lunz JG 3rd, Specht S, Murase N, Marcos A 2006 Wound healing in the biliary tree of liver allografts. Cell Transplant. 15 Suppl. 1: S57-S65.

• Demetris AJ, Lunz JG 3rd, Specht S, Nozaki I 2006 Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease. World J. Gastroenterol. 12: 3512-3522. *

• Der G, Love T, Schreck J, Horn M 2005 Primary sclerosing cholangitis: a case presentation. Gastroenterol. Nurs. 28: 13-16. *

• Dewitt J, Misra VL, Leblanc JK, McHenry L, Sherman S 2006 EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results. Gastrointest. Endosc. 64: 325-333.

• Dezza MC, Berrevoet F, Sainz-Barriga M, Rossetto A, Colenbie L, Haentjens I, Van Vlierberghe H, Colle I, Van Huysse J, Praet M, Rogiers X, de Hemptinne B, Troisi R 2007 The choice of recipient does not have a bearing on early outcome in liver transplant patients receiving grafts from non-heart-beating donors: a reappraisal? Transplant. Proc. 39: 2675-2677.

• Dikengil A, Siskind BN, Morse SS, Swedlund A, Bober-Sorcinelli KE, Burrell MI 1986 Sclerosing cholangitis from intraarterial floxuridine. J. Clin. Gastroenterol. 8: 690-693.

• Distante V, Farouk M, Kurzawinski TR, Ahmed SW, Burroughs AK, Davidson BR, Rolles K 1996 Duct-to-duct biliary reconstruction following liver transplantation for primary sclerosing cholangitis. Transpl. Int. 9: 126-130.

• Dolmatch BL, Laing FC, Ferderle MP, Jeffrey RB, Cello J 1987 AIDS-related cholangitis: radiographic findings in nine patients. Radiology 163: 313-316. *

• Domagk D, Wessling J, Reimer P, Hertel L, Poremba C, Senninger N, Heinecke A, Domschke W, Menzel J 2004 Endoscopic retrograde cholangiopancreatography, intraductal ultrasonography, and magnetic resonance cholangiopancreatography in bile duct strictures: a prospective comparison of imaging diagnostics with histopathological correlation. Am. J. Gastroenterol. 99: 1684-1689. *

• Domajnko B, Ahrendt SA 2005 Indications for non-transplant surgery in primary sclerosing cholangitis. HPB (Oxford) 7: 292-297. *

• Dumonceau JM, Casco C, Landoni N, Frossard JL, Hadengue A, Pache JC, Genevay M, Morel P, Kumar N, Bongiovanni M 2007 A new method of biliary sampling for cytopathological examination during endoscopic retrograde cholangiography. Am. J. Gastroenterol. 102: 550-557. *

• Dumonceau JM, Cremer M, Auroux J, Delhaye M, Deviere J 2000 A comparison of Ultraflex Diamond stents and Wallstents for palliation of distal malignant biliary strictures. Am. J. Gastroenterol. 95: 670-676. *

• Dumonceau JM, Deviere J 1999 The ultraflex diamond stent for malignant biliary obstruction. Gastrointest. Endosc. Clin. N. Am. 9: 513-520.

• Dumonceau JM, Deviere J, Delhaye M, Baize M, Cremer M 1998 Plastic and metal stents for postoperative benign bile duct strictures: the best and the worst. Gastrointest. Endosc. 47: 8-17. *

• Dumonceau JM, Macias Gomez C, Casco C, Genevay M, Marcolongo M, Bongiovanni M, Morel P, Majno P, Hadengue A 2007 Grasp or brush for biliary sampling at endoscopic retrograde cholangiography? A blinded randomized controlled trial. Am. J. Gastroenterol. 103: 333-340. *

• Dumonceau JM, Nicaise N, Deviere J 1999 The ultraflex diamond stent for benign biliary obstruction. Gastrointest. Endosc. Clin. N. Am. 9: 541-545.

• Durieu I, Pellet O, Simonot L, Durupt S, Bellon G, Durand DV, Minh VA 1999 Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic prospective study. J. Hepatol. 30: 1052-1056. *

• Eickhoff A, Schilling D, Jakobs R, Weickert U, Hartmann D, Eickhoff JC, Riemann JF 2005 Long-term outcome of percutaneous transhepatic drainage for benign bile duct stenoses. Rocz. Akad. Med. Bialymst. 50: 155-160.

• Epstein O, Ajdukiewicz AB, Dick R, Sherlock S 1979 Hypertrophic hepatic osteoarthropathy. Clinical, roentgenologic, biochemical, hormonal and cardiorespiratory studies, and review of the literature. Am. J. Med. 67: 88-97.

• Erdogan D, Kloek JJ, Ten Kate FJ, Rauws EA, Busch OR, Gouma DJ, van Gulik TM 2008 Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures. Br. J. Surg. 95: 727-734.

• Erlinger S 1997 Drug-induced cholestasis. J. Hepatol. 26 Suppl. 1: 1-4.

• Etzel JP, Eng SC, Ko CW, Lee SD, Saunders MD, Tung BY, Kimmey MB, Kowdley KV 2008 Complications after ERCP in patients with primary sclerosing cholangitis. Gastrointest. Endosc. 67: 643-648.

• Faust TW 2000 Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation. Semin. Liver Dis. 20: 481-495. *

• Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Weiglein AH, Lammert F, Marschall HU, Tsybrovskyy O, Zatloukal K, Denk H, Trauner M 2002 Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 123: 1238-1251. *

• Fogel EL, McHenry L, Sherman S, Watkins JL, Lehman GA 2005 Therapeutic biliary endoscopy. Endoscopy 37: 139-145.

• Fogel EL, Sherman S, Park SH, McHenry L, Lehman GA 2003 Therapeutic biliary endoscopy. Endoscopy 35: 156-163.

• Fracchia M, Soubrane O, Houssin D, Galatola G 1995 Temporary resolution of obstructive jaundice during ursodeoxycholic acid therapy in a patient with primary sclerosing cholangitis and a dominant biliary stricture. Ital. J. Gastroenterol. 27: 430-435.

• Franco J, Saeian K 1999 Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis. Curr. Gastroenterol. Rep. 1: 95-101.

• Freeman ML, Cass OW, Dailey J 2001 Dilation of high-grade pancreatic and biliary ductal strictures with small-caliber angioplasty balloons. Gastrointest. Endosc. 54: 89-92. *

• Fritscher-Ravens A, Broering DC, Knoefel WT, Rogiers X, Swain P, Thonke F, Bobrowski C, Topalidis T, Soehendra N 2004 EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am. J. Gastroenterol. 99: 45-51. *

• Fulcher AS 2004 CT cholangiography: advantages and disadvantages compared with MR cholangiography in the evaluation of the biliary tract following liver transplantation. Liver Transpl. 10: 1071-1072. *

• Galandi D, Schwarzer G, Bassler D, Allgaier HP 2002 Ursodeoxycholic acid and/or antibiotics for prevention of biliary stent occlusion. Cochrane Database Syst. Rev. 3: CD003043. *

• Gardikis S, Antypas S, Kambouri K, Lainakis N, Panagidis A, Deftereos S, Polychronidis A, Dolatzas T, Simopoulos C 2005 The Roux-en-Y procedure in congenital hepato-biliary disorders. Rom. J. Gastroenterol. 14: 135-140. *

• Garrow D, Miller S, Sinha D, Conway J, Hoffman BJ, Hawes RH, Romagnuolo J 2007 Endoscopic ultrasound: a meta-analysis of test performance in suspected biliary obstruction. Clin. Gastroenterol. Hepatol. 5: 616-623.

• Gaskin KJ, Waters DL, Howman-Giles R, de Silva M, Earl JW, Martin HC, Kan AE, Brown JM, Dorney SF 1988 Liver disease and common-bile-duct stenosis in cystic fibrosis. N. Engl. J. Med. 318: 340-346.

• Gelbmann CM, Rummele P, Wimmer M, Hofstadter F, Gohlmann B, Endlicher E, Kullmann F, Langgartner J, Scholmerich J 2007 Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am. J. Gastroenterol. 102: 1221-1229. *

• Geng ZM, Zheng JB, Zhang XX, Tao J, Wang L 2008 Role of transforming growth factor-beta signaling pathway in pathogenesis of benign biliary stricture. World J. Gastroenterol. 14: 4949-4954. *

• Geuken E, Visser D, Kuipers F, Blokzijl H, Leuvenink HG, de Jong KP, Peeters PM, Jansen PL, Slooff MJ, Gouw AS, Porte RJ 2004 Rapid increase of bile salt secretion is associated with bile duct injury after human liver transplantation. J. Hepatol. 41: 1017-1025. *

• Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ, Topazian MD, Clain JE, Pearson RK, Petersen BT, Vege SS, Lindor K, Farnell MB 2008 Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 134: 706-715. *

• Girometti R, Cereser L, Como G, Zuiani C, Bazzocchi M 2008 Biliary complications after orthotopic liver transplantation: MRCP findings. Abdom. Imaging 33: 542-554. *

• Glasbrenner B, Ardan M, Boeck W, Preclik G, Moller P, Adler G 1999 Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy 31: 712-717.

• Gluck M, Cantone NR, Brandabur JJ, Patterson DJ, Bredfeldt JE, Kozarek RA 2008 A twenty-year experience with endoscopic therapy for symptomatic primary sclerosing cholangitis. J. Clin. Gastroenterol. Jun 17 [Epub ahead of print].

• Gohlke F, Lohse AW, Dienes HP, Lohr H, Marker-Hermann E, Gerken G, Meyer zum Buschenfelde KH 1996 Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J. Hepatol. 24: 699-705. *

• Goldberg HI 1992 Imaging of the biliary tract. Curr. Opin. Radiol. 4: 62-69.

• Goldstein ES, Rubin PH 2003 Endoscopic therapy for inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 6: 237-243.

• Gondoh K, Ono T, Miyakoda K, Mukasa M, So A, Imamura K, Sata M 2006 Bezafibrate alone is an effective first-line therapy for primary sclerosing cholangitis: a case report. Nippon Shokakibyo Gakkai Zasshi 103: 643-649.

• Gopal DV, Pfau PR, Lucey MR 2003 Endoscopic management of biliary complications after orthotopic liver transplantation. Curr. Treat. Options Gastroenterol. 6: 509-515.

• Gordon F 2006 Recurrent primary sclerosing cholangitis: clinical diagnosis and long-term management issues. Liver Transpl. 12: S73-S75. *

• Gores GJ, Baskin-Bey ES, Baron TH, Alberts SR 2004 Treatment endpoints for advanced cholangiocarcinoma. Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 4-5. *

• Gossard AA, Lindor KD 2000 Medical management of chronic cholestatic liver diseases. Can. J. Gastroenterol. 14 Suppl. D: 93D-98D.

• Gossard AA, Lindor KD 2002 Pregnancy in a patient with primary sclerosing cholangitis. J. Clin. Gastroenterol. 35: 353-355.

• Graziadei IW 2002 Recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl. 8: 575-581. *

• Graziadei IW, Wiesner RH, Batts KP, Marotta PJ, LaRusso NF, Porayko MK, Hay JE, Gores GJ, Charlton MR, Ludwig J, Poterucha JJ, Steers JL, Krom RA 1999 Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology 29: 1050-1056. *

• Graziadei IW, Wiesner RH, Marotta PJ, Porayko MK, Hay JE, Charlton MR, Poterucha JJ, Rosen CB, Gores GJ, LaRusso NF, Krom RA 1999 Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 30: 1121-1127. *

• Gress TM 2004 Molecular diagnosis of pancreatobiliary malignancies in brush cytologies of biliary strictures. Gut 53: 1727-1729. *

• Grewal HP, Shokouh-Amiri MH, Vera S, Stratta R, Bagous W, Gaber AO 2001 Surgical technique for right lobe adult living donor liver transplantation without venovenous bypass or portocaval shunting and with duct-to-duct biliary reconstruction. Ann. Surg. 233: 502-508. *

• Guarise A, Venturini S, Faccioli N, Pinali L, Morana G 2006 Role of magnetic resonance in characterising extrahepatic cholangiocarcinomas. Radiol. Med. (Torino) 111: 526-538.

• Guerrero Hernandez I, Weimersheimer Sandoval M, Lopez Mendez E, Hernandez Calleros J, Tapia AR, Uribe M 2005 Biliary stricture caused by portal biliopathy: case report and literature review. Ann. Hepatol. 4: 286-288. *

• Guichelaar MM, Benson JT, Malinchoc M, Krom RA, Wiesner RH, Charlton MR 2003 Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation. Am. J. Transplant. 3: 885-890. *

• Gulliver DJ, Baker ME, Putnam W, Baillie J, Rice R, Cotton PB 1991 Bile duct diverticula and webs: nonspecific cholangiographic features of primary sclerosing cholangitis. AJR Am. J. Roentgenol. 157: 281-285. *

• Hadjis NS, Adam A, Hatzis G, Blenkharn I, Thompson IW, Blumgart LH 1988 Primary sclerosing cholangitis: symptomatic and cholangiographic improvement after peripheral drainage. Am. J. Gastroenterol. 83: 312-315.

• Hampe T, Dogan A, Encke J, Mehrabi A, Schemmer P, Schmidt J, Stiehl A, Sauer P 2006 Biliary complications after liver transplantation. Clin. Transplant. 20 Suppl. 17: 93-96. *

• Harewood GC, Baron TH, Stadheim LM, Kipp BR, Sebo TJ, Salomao DR 2004 Prospective, blinded assessment of factors influencing the accuracy of biliary cytology interpretation. Am. J. Gastroenterol. 99: 1464-1469. *

• Harrison J, McMaster P 1994 The role of orthotopic liver transplantation in the management of sclerosing cholangitis. Hepatology 20: 14S-19S.

• Harrison PM 1999 Diagnosis of primary sclerosing cholangitis. J. Hepatobiliary Pancreat. Surg. 6: 356-360.

• Hausegger KA, Mischinger HJ, Karaic R, Klein GE, Kugler C, Kern R, Uggowitzer M, Szolar D 1997 Percutaneous cholangioscopy in obstructed biliary metal stents. Cardiovasc. Intervent. Radiol. 20: 191-196.

• Heffron TG, Smallwood GA, Ramcharan T, Davis L, Connor K, Martinez E, Stieber AC 2003 Duct-to-duct biliary anastomosis for patients with sclerosing cholangitis undergoing liver transplantation. Transplant. Proc. 35: 3006-3007. *

• Helmberger H, Hellerhoff K, Rull T, Rosch T 2000 Chronic infections of the biliary system. Radiologe 40: 530-536.

• Helton WS, Espat NJ 2001 Cholecystitis and cholangitis. Curr. Treat. Opt. Infect. Dis. 3: 387-400. *

• Hirai I, Ishiyama S, Fuse A, Kuzu H, Sakurai F, Kimura S, Kimura W 2001 Primary sclerosing cholangitis successfully treated by resection of the confluence of the hepatic duct. J. Hepatobiliary Pancreat. Surg. 8: 169-173.

• Hirano K, Shiratori Y, Komatsu Y, Yamamoto N, Sasahira N, Toda N, Isayama H, Tada M, Tsujino T, Nakata R, Kawase T, Katamoto T, Kawabe T, Omata M 2003 Involvement of the biliary system in autoimmune pancreatitis: a follow-up study. Clin. Gastroenterol. Hepatol. 1: 453-464. *

• Hoffman A, Kiesslich R, Bittinger F, Galle PR, Neurath MF 2008 Methylene-blue-aided cholangioscopy in patients with biliary strictures: feasibility and outcome analysis. Endoscopy 40: 563-571.

• Holtmeier J, Leuschner U 2001 Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis. Digestion 64: 137-150. *

• Hookey LC, Le Moine O, Deviere J 2005 Use of a temporary plastic stent to facilitate the placement of multiple self-expanding metal stents in malignant biliary hilar strictures. Gastrointest. Endosc. 62: 605-609.

• Huang CS, Lichtenstein DR 2005 Treatment of biliary problems in inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 8: 117-126.

• Huibregtse K 1999 The Wallstent for malignant biliary obstruction. Gastrointest. Endosc. Clin. N. Am. 9: 491-501.

• Humar A 2004 Living donor liver transplants: potential disadvantages. J. Gastroenterol. Hepatol. 19: S304-S306. *

• Hutson DG, Russell E, Levi JU, Jeffers LJ, Reddy KR, Yrizarry JM, Scagnelli T, Sleeman D, Schiff ER, Livingstone AS 2001 Dilatation of biliary strictures through the afferent limb of a Roux-en-Y choledochojejunostomy in patients with sclerosing cholangitis. World J. Surg. 25: 1251-1253. *

• Hutson DG, Russell E, Schiff E, Levi JJ, Jeffers L, Zeppa R 1984 Balloon dilatation of biliary strictures through a choledochojejuno-cutaneous fistula. Ann. Surg. 199: 637-647. *

• Isayama H, Kawabe T, Nakai Y, Tsujino T, Sasahira N, Yamamoto N, Arizumi T, Togawa O, Matsubara S, Ito Y, Sasaki T, Hirano K, Toda N, Komatsu Y, Tada M, Yoshida H, Omata M 2006 Cholecystitis after metallic stent placement in patients with malignant distal biliary obstruction. Clin. Gastroenterol. Hepatol. 4: 1148-1153.

• Ishak KG 1998 Sarcoidosis of the liver and bile ducts. Mayo Clin. Proc. 73: 467-472.

• Issa H, Al-Haddad A, Al-Salem AH 2007 Diagnostic and therapeutic ERCP in the pediatric age group. Pediatr. Surg. Int. 23: 111-116. *

• Jha R, Al-Kawas FH 2004 How good is IDUS in patients with isolated biliary strictures? Am. J. Gastroenterol. 99: 1690-1691. *

• Johnson GK, Geenen JE, Venu RP, Schmalz MJ, Hogan WJ 1991 Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: a larger series and recommendations for treatment. Gastrointest. Endosc. 37: 38-43.

• Johnson GK, Saeian K, Geenen JE 2006 Primary sclerosing cholangitis treated by endoscopic biliary dilation: review and long-term follow-up evaluation. Curr. Gastroenterol. Rep. 8: 147-155.

• Johnson SR, Koehler A, Pennington LK, Hanto DW 2000 Long-term results of surgical repair of bile duct injuries following laparoscopic cholecystectomy. Surgery 128: 668-677. *

• Joyce AM, Kochman ML 2005 Update on biliary endoscopy. Curr. Opin. Gastroenterol. 21: 354-358.

• Kaassis M, Boyer J, Dumas R, Ponchon T, Coumaros D, Delcenserie R, Canard JM, Fritsch J, Rey JF, Burtin P 2003 Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest. Endosc. 57: 178-182. *

• Kaczmarek B, Manas MD, Jaques BC, Talbot D 2007 Ischemic cholangiopathy after liver transplantation from controlled non-heart-beating donors-a single-center experience. Transplant. Proc. 39: 2793-2795. *

• Kahaleh M, Behm B, Clarke BW, Brock A, Shami VM, De La Rue SA, Sundaram V, Tokar J, Adams RB, Yeaton P 2008 Temporary placement of covered self-expandable metal stents in benign biliary strictures: a new paradigm? (with video). Gastrointest. Endosc. 67: 446-454.

• Kahl S, Zimmermann S, Genz I, Glasbrenner B, Pross M, Schulz HU, Mc Namara D, Schmidt U, Malfertheiner P 2003 Risk factors for failure of endoscopic stenting of biliary strictures in chronic pancreatitis: a prospective follow-up study. Am. J. Gastroenterol. 98: 2448-2453. *

• Kahl S, Zimmermann S, Glasbrenner B, Pross M, Schulz HU, McNamara D, Malfertheiner P 2002 Treatment of benign biliary strictures in chronic pancreatitis by self-expandable metal stents. Dig. Dis. 20: 199-203.

• Kaltenthaler EC, Walters SJ, Chilcott J, Blakeborough A, Vergel YB, Thomas S 2006 MRCP compared to diagnostic ERCP for diagnosis when biliary obstruction is suspected: a systematic review. BMC Med. Imaging 6: 9. *

• Kaplowitz N 2004 Hepatology highlights. Hepatology 39: 271-272. *

• Kaw M, Silverman WB, Rabinovitz M, Schade RR 1995 Biliary tract calculi in primary sclerosing cholangitis. Am. J. Gastroenterol. 90: 72-75.

• Kemeny MM, Battifora H, Blayney DW, Cecchi G, Goldberg DA, Leong LA, Margolin KA, Terz JJ 1985 Sclerosing cholangitis after continuous hepatic artery infusion of FUDR. Ann. Surg. 202: 176-181. *

• Khalid A, Pal R, Sasatomi E, Swalsky P, Slivka A, Whitcomb D, Finkelstein S 2004 Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples. Gut 53: 1860-1865. *

• Khalili K, Metser U, Wilson SR 2003 Hilar biliary obstruction: preliminary results with Levovist-enhanced sonography. AJR Am. J. Roentgenol. 180: 687-693. *

• Khan MH, Howard TJ, Fogel EL, Sherman S, McHenry L, Watkins JL, Canal DF, Lehman GA 2007 Frequency of biliary complications after laparoscopic cholecystectomy detected by ERCP: experience at a large tertiary referral center. Gastrointest. Endosc. 65: 247-252.

• Khanna N, May G, Bass S, Cole M, Romagnuolo J 2008 Postprocedural interpretation of endoscopic retrograde cholangiopancreatography by radiology. Can. J. Gastroenterol. 22: 55-60.

• Khuroo MS, Al Ashgar H, Khuroo NS, Khan MQ, Khalaf HA, Al-Sebayel M, El Din Hassan MG 2005 Biliary disease after liver transplantation: the experience of the King Faisal Specialist Hospital and Research Center, Riyadh. J. Gastroenterol. Hepatol. 20: 217-228. *

• Kilicoglu B, Kismet K, Kilicoglu SS, Erel S, Gencay O, Sorkun K, Erdemli E, Akhan O, Akkus MA, Sayek I 2008 Effects of honey as a scolicidal agent on the hepatobiliary system. World J. Gastroenterol. 14: 2085-2088. *

• Kim HJ, Park DI, Park JH, Cho YK, Sohn CI, Jeon WK, Kim BI, Kim SK 2007 Multidetector computed tomography cholangiography with multiplanar reformation for the assessment of patients with biliary obstruction. J. Gastroenterol. Hepatol. 22: 400-405. *

• Kim JY, Lee JM, Han JK, Kim SH, Lee JY, Choi JY, Kim SJ, Kim HJ, Kim KH, Choi BI 2007 Contrast-enhanced MRI combined with MR cholangiopancreatography for the evaluation of patients with biliary strictures: differentiation of malignant from benign bile duct strictures. J. Magn. Reson. Imaging 26: 304-312.

• Kipp BR, Stadheim LM, Halling SA, Pochron NL, Harmsen S, Nagorney DM, Sebo TJ, Therneau TM, Gores GJ, Groen PC, Baron TH, Levy MJ, Halling KC, Roberts LR 2004 A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am. J. Gastroenterol. 99: 1675-1681. *

• Kita R, Kita-Sasai Y, Hanaoka I, Kimura T, Kokuryu H, Takamatsu S, Osaki Y, Tomono N, Hachiya T, Shimizu T 2002 Beneficial effect of bezafibrate on primary sclerosing cholangitis (three case reports). Am. J. Gastroenterol. 97: 1849-1851. *

• Kitajima Y, Ohara H, Nakazawa T, Ando T, Hayashi K, Takada H, Tanaka H, Ogawa K, Sano H, Togawa S, Naito I, Hirai M, Ueno K, Ban T, Miyabe K, Yamashita H, Yoshimura N, Akita S, Gotoh K, Joh T 2007 Usefulness of transpapillary bile duct brushing cytology and forceps biopsy for improved diagnosis in patients with biliary strictures. J. Gastroenterol. Hepatol. 22: 1615-1620. *

• Kitano Y, Matsumoto K, Chisaka K, Imazawa M, Takahashi K, Nakade Y, Okada M, Aso K, Yokoyama K, Yamamoto M, Yoshie M, Ogawa K, Haneda M 2007 An autopsy case of autoimmune pancreatitis. JOP 8: 621-627. *

• Klimstra DS, Adsay NV 2004 Lymphoplasmacytic sclerosing (autoimmune) pancreatitis. Semin. Diagn. Pathol. 21: 237-246.

• Kling K, Lau H, Colombani P 2004 Biliary complications of living related pediatric liver transplant patients. Pediatr. Transplant. 8: 178-184. *

• Ko SB, Naruse S, Ishiguro H, Yoshikawa T, Yamamoto T, Futakuchi S, Goto H 2007 Allochronic biliary strictures appeared in the different regions of the bile duct tree in a patient with autoimmune pancreatitis. Pancreas 34: 479-481.

• Kocher M, Cerna M, Havlik R, Kral V, Gryga A, Duda M 2007 Percutaneous treatment of benign bile duct strictures. Eur. J. Radiol. 62: 170-174.

• Koivusalo A, Isoniemi H, Salmela K, Hockerstedt K 1994 Biliary complications in 100 adult liver transplantations: a retrospective clinical study. Transpl. Int. 7: 119-120.

• Kojima E, Kimura K, Noda Y, Kobayashi G, Itoh K, Fujita N 2003 Autoimmune pancreatitis and multiple bile duct strictures treated effectively with steroid. J. Gastroenterol. 38: 603-607.

• Kolin E, Mena IG 1989 Cholescintigraphy in AIDS-related cholangitis: a case report. Clin. Nucl. Med. 14: 725-727.

• Komatsu K, Shimosegawa T, Kikuchi S, Uchi M, Maruhama Y, Kisara N, Ueno Y, Toyota T 2000 Paradoxical progression of biliary strictures against recovery of biochemical parameters under ursodeoxycholic acid treatment in a case of primary sclerosing cholangitis with ulcerative colitis. Intern. Med. 39: 1049-1053. *

• Krige JE, Terblanche J, Harries-Jones EP, Bornman PC 1987 Primary sclerosing cholangitis: biliary drainage and duct dilatation. Br. J. Surg. 74: 54-57.

• Krishna M, Keaveny AP, Genco PV, Rosser BG, Dickson RC, Nguyen JH, Steers JL, Nakhleh RE 2005 Clinicopathological review of 18 cases of liver allografts lost due to bile duct necrosis. Transplant. Proc. 37: 2221-2223. *

• Kubota T, Thomson A, Clouston AD, Nakazawa Y, Steadman C, Kerlin P, Shimada H, Balderson GA, Lynch SV, Strong RW 1999 Clinicopathologic findings of recurrent primary sclerosing cholangitis after orthotopic liver transplantation. J. Hepatobiliary Pancreat. Surg. 6: 377-381.

• Kukuruzovic R, Chauhan S, Dorney S, Elliott E 2004 Antibiotics for cholangitis and/or cholecystitis. Cochrane Database Syst. Rev. 2: CD003780. *

• Kumagi T, Alswat K, Hirschfield GM, Heathcote J 2008 New insights into autoimmune liver diseases. Hepatol. Res. 38: 745-761. *

• Kurzawinski T, Deery A, Davidson BR 1993 Diagnostic value of cytology for biliary stricture. Br. J. Surg. 80: 414-421.

• Kurzawinski TR, Deery A, Dooley JS, Dick R, Hobbs KE, Davidson BR 1993 A prospective study of biliary cytology in 100 patients with bile duct strictures. Hepatology 18: 1399-1403.

• Lakshmi MV, Sridharan GV, Butterworth D 1993 Gallstone cirrhosis: are we only seeing the tip of the iceberg? Br. J. Clin. Pract. 47: 164-165.

• Lal R, Agarwal S, Shivhare R, Kumar A, Sikora SS, Kapoor VK, Saxena R 2007 Management of complicated choledochal cysts. Dig. Surg. 24: 456-462.

• Lazaridis KN, Gores GJ 2006 Primary sclerosing cholangitis and cholangiocarcinoma. Semin. Liver Dis. 26: 42-51. *

• Lebovics E, Salama M, Elhosseiny A, Rosenthal WS 1992 Resolution of radiographic abnormalities with ursodeoxycholic acid therapy of primary sclerosing cholangitis. Gastroenterology 102: 2143-2147.

• Lee KW, Joh JW, Kim SJ, Choi SH, Heo JS, Lee HH, Park JW, Lee SK 2004 High hilar dissection: new technique to reduce biliary complication in living donor liver transplantation. Liver Transpl. 10: 1158-1162. *

• Lee S 2004 Gallstones: how do we translate an old story into future therapy? Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 2-3. *

• Lee VS, Morgan GR, Lin JC, Nazzaro CA, Chang JS, Teperman LW, Krinsky GA 2004 Liver transplant donor candidates: associations between vascular and biliary anatomic variants. Liver Transpl. 10: 1049-1054. *

• Lee WJ, Lim HK, Jang KM, Kim SH, Lee SJ, Lim JH, Choo IW 2001 Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses. Radiographics 21: 97-116. *

• Lee YM 2002 Motion - patients with primary sclerosing cholangitis should undergo early liver transplantation: arguments for the motion. Can. J. Gastroenterol. 16: 697-699.

• Lee YM, Kaplan MM 1999 Medical treatment of primary sclerosing cholangitis. J. Hepatobiliary Pancreat. Surg. 6: 361-365.

• Lee YM, Kim DJ 2001 Primary sclerosing cholangitis. Curr. Treat. Options Gastroenterol. 4: 469-477.

• Lefkowitch JH 2008 Hepatobiliary pathology. Curr. Opin. Gastroenterol. 24: 269-277.

• Lemmer ER, Bornman PC, Krige JE, Wright JP, Beningfield S, Jaskiewicz K, Kirsch RE, Kahn D, Terblanche JT, Robson SC 1994 Primary sclerosing cholangitis. Requiem for biliary drainage operations? Arch. Surg. 129: 723-728.

• Lemmer ER, Spearman CW, Krige JE, Millar AJ, Bornman PC, Terblanche J, Kahn D 1997 The management of biliary complications following orthotopic liver transplantation. S. Afr. J. Surg. 35: 77-81.

• Lempinen M, Isoniemi H, Makisalo H, Nordin A, Halme L, Arola J, Hockerstedt K, Stenman UH 2007 Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures. J. Hepatol. 47: 677-683. *

• Levy C, Lindor KD 2003 Treatment options for primary biliary cirrhosis and primary sclerosing cholangitis. Curr. Treat. Options Gastroenterol. 6: 93-103.

• Levy C, Lindor KD 2003 Management of primary biliary cirrhosis. Curr. Treat. Options Gastroenterol. 6: 493-498.

• Levy C, Lindor KD 2003 Current management of primary biliary cirrhosis and primary sclerosing cholangitis. J. Hepatol. 38: S24-S37. *

• Levy MJ, Baron TH, Clayton AC, Enders FB, Gostout CJ, Halling KC, Kipp BR, Petersen BT, Roberts LR, Rumalla A, Sebo TJ, Topazian MD, Wiersema MJ, Gores GJ 2008 Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures. Am. J. Gastroenterol. 103: 1263-1273.

• Lillemoe KD, Melton GB, Cameron JL, Pitt HA, Campbell KA, Talamini MA, Sauter PA, Coleman J, Yeo CJ 2000 Postoperative bile duct strictures: management and outcome in the 1990s. Ann. Surg. 232: 430-441. *

• Lillemoe KD, Pitt HA, Cameron JL 1990 Primary sclerosing cholangitis. Surg. Clin. North Am. 70: 1381-1402.

• Lillemoe KD, Pitt HA, Cameron JL 1992 Current management of benign bile duct strictures. Adv. Surg. 25: 119-174.

• Lillemoe KD, Pitt HA, Cameron JL 1988 Sclerosing cholangitis. Adv. Surg. 21: 65-92.

• Lindberg B, Arnelo U, Bergquist A, Thorne A, Hjerpe A, Granqvist S, Hansson LO, Tribukait B, Persson B, Broome U 2002 Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. Endoscopy 34: 909-916.

• Linder S, Soderlund C 2001 Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer. Hepatogastroenterology 48: 387-392.

• Listrom C, Holt K 2004 Inflammatory bowel disease. Emerg. Med. 36: 24-28.

• Liu CL, Lo CM, Chan SC, Fan ST 2004 Safety of duct-to-duct biliary reconstruction in right-lobe live-donor liver transplantation without biliary drainage. Transplantation 77: 726-732.

• Lombard M, Farrant M, Karani J, Westaby D, Williams R 1991 Improving biliary-enteric drainage in primary sclerosing cholangitis: experience with endoscopic methods. Gut 32: 1364-1368. *

• Lopez MJ, Lee YM 2005 Primary sclerosing cholangitis and primary biliary cirrhosis. The American College of Gastroenterology (http://www.acg.gi.org/patients/gihealth/pdf/sclerosing.pdf). *

• Lopez RR Jr, Cosenza CA, Lois J, Hoffman AL, Sher LS, Noguchi H, Pan SH, McMonigle M 2001 Long-term results of metallic stents for benign biliary strictures. Arch. Surg. 136: 664-669. *

• Lubienski A, Duex M, Lubienski K, Blietz J, Kauffmann GW, Helmberger T 2005 Interventions for benign biliary strictures. Radiologe 45: 1012-1019.

• MacCarty RL, LaRusso NF, Wiesner RH, Ludwig J 1983 Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology 149: 39-44. *

• MacFaul GR, Chapman RW 2004 Sclerosing cholangitis. Curr. Opin. Gastroenterol. 20: 275-280.

• Macken E, Drijkoningen M, Van Aken E, Van Steenbergen W 2000 Brush cytology of ductal strictures during ERCP. Acta Gastroenterol. Belg. 63: 254-259.

• Mandal A, Dasgupta A, Jeffers L, Squillante L, Hyder S, Reddy R, Schiff E, Das KM 1994 Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium. Gastroenterology 106: 185-192.

• Mansfield JC, Griffin SM, Wadehra V, Matthewson K 1997 A prospective evaluation of cytology from biliary strictures. Gut 40: 671-677. *

• Margalit M, Elinav H, Goldin E, Ilan Y 2003 Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"? Harefuah. 142: 421-425.

• Marrache F, Hammel P, O'Toole D, Cazals-Hatem D, Vullierme MP, Sibert A, Ponsot P, Maire F, Hentic O, Sauvanet A, Levy P, Ruszniewski P 2005 Severe cholangitis following pancreaticoduodenectomy for pseudotumoral form of lymphoplasmacytic sclerosing pancreatitis. Am. J. Gastroenterol. 100: 2808-2813. *

• Martin EC, Fankuchen EI, Laffey KJ, Sibley RE 1984 Percutaneous management of benign biliary disease. Gastrointest. Radiol. 9: 207-212.

• Mascarenhas MR 2003 Treatment of gastrointestinal problems in cystic fibrosis. Curr. Treat. Options Gastroenterol. 6: 427-441.

• McLoughlin M, Enns R 2008 Endoscopy in the management of primary sclerosing cholangitis. Curr. Gastroenterol. Rep. 10: 177-185.

• Meenan J, Rauws EA, Huibregtse K 1996 Benign biliary strictures and sclerosing cholangitis. Gastrointest. Endosc. Clin. N. Am. 6: 127-138.

• Meier PN, Manns MP 2001 Medical and endoscopic treatment in primary sclerosing cholangitis. Best Pract. Res. Clin. Gastroenterol. 15: 657-666. *

• Mendes FD, Jorgensen R, Keach J, Katzmann JA, Smyrk T, Donlinger J, Chari S, Lindor KD 2006 Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am. J. Gastroenterol. 101: 2070-2075. *

• Mendler MH, Bouillet P, Sautereau D, Chaumerliac P, Cessot F, Le Sidaner A, Pillegand B 1998 Value of MR cholangiography in the diagnosis of obstructive diseases of the biliary tree: a study of 58 cases. Am. J. Gastroenterol. 93: 2482-2490. *

• Menon K, Romagnuolo J, Barkun AN 2001 Expandable metal biliary stenting in patients with recurrent premature polyethylene stent occlusion. Am. J. Gastroenterol. 96: 1435-1440. *

• Menzel J, Poremba C, Dietl KH, Domschke W 2000 Preoperative diagnosis of bile duct strictures - comparison of intraductal ultrasonography with conventional endosonography. Scand. J. Gastroenterol. 35: 77-82. *

• Meyenberger Ch, Fantin AC 2003 Biliary stents. Ther. Umsch. 60: 225-232.

• Miller GA, Yeh BM, Breiman RS, Roberts JP, Qayyum A, Coakley FV 2004 Use of CT cholangiography to evaluate the biliary tract after liver transplantation: initial experience. Liver Transpl. 10: 1065-1070. *

• Moff SL, Kamel IR, Eustace J, Lawler LP, Kantsevoy S, Kalloo AN, Thuluvath PJ 2006 Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography. Gastrointest. Endosc. 64: 219-223.

• Molnar W, Stockum AE 1978 Transhepatic dilatation of choledochoenterostomy strictures. Radiology 129: 59-64.

• Morelli A, Narducci F, Pelli MA, Ciccone R, Rossi L, Gubbiotti A 1978 Transendoscopic retrograde cholangiography in the diagnosis of primary sclerosing cholangitis. Study of 6 cases. Minerva Med. 69: 3565-3570.

• Moreno Luna LE, Kipp B, Halling KC, Sebo TJ, Kremers WK, Roberts LR, Barr Fritcher EG, Levy MJ, Gores GJ 2006 Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures. Gastroenterology 131: 1064-1072. *

• Murray MD, Burton FR, Di Bisceglie AM 2007 Markedly elevated serum CA 19-9 levels in association with a benign biliary stricture due to primary sclerosing cholangitis. J. Clin. Gastroenterol. 41: 115-117.

• Myburgh JA 1994 Surgical biliary drainage in primary sclerosing cholangitis. The role of the Hepp-Couinaud approach. Arch. Surg. 129: 1057-1062.

• Nagel RA, Westaby D, Javaid A, Kavani J, Meire HB, Lombard MG, Wise A, Williams R, Hodson ME 1989 Liver disease and bile duct abnormalities in adults with cystic fibrosis. Lancet 2: 1422-1425.

• Nakeeb A, Lipsett PA, Lillemoe KD, Fox-Talbot MK, Coleman J, Cameron JL, Pitt HA 1996 Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma. Am. J. Surg. 171: 147-152.

• Nazareno J, Taves D, Preiksaitis HG 2006 Metastatic breast cancer to the gastrointestinal tract: a case series and review of the literature. World J. Gastroenterol. 12: 6219-6224. *

• Negi SS, Chaudhary A 2005 Analysis of abnormal recovery pattern of liver function tests after surgical repair of bile duct strictures. J. Gastroenterol. Hepatol. 20:1533-1537. *

• Nehls O, Gregor M, Klump B 2004 Serum and bile markers for cholangiocarcinoma. Semin. Liver Dis. 24: 139-154.

• Neuberger J 2003 Liver transplantation for cholestatic liver disease. Curr. Treat. Options Gastroenterol. 6: 113-121.

• Neuberger J 2004 Liver transplantation for autoimmune liver diseases. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 82-83. *

• Ng SS, Yu SC, Lai PB, Lau WY 2008 Biliary complications associated with selective internal radiation (SIR) therapy for unresectable liver malignancies. Dig. Dis. Sci. 53: 2813-2817. *

• Nishida S, Nakamura N, Kadono J, Komokata T, Sakata R, Madariaga JR, Tzakis AG 2006 Intrahepatic biliary strictures after liver transplantation. J. Hepatobiliary Pancreat. Surg. 13: 511-516. *

• Nishino T, Toki F, Oyama H, Oi I, Kobayashi M, Takasaki K, Shiratori K 2005 Biliary tract involvement in autoimmune pancreatitis. Pancreas 30: 76-82.

• No authors listed 2002 NIH state-of-the-science statement on endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy. NIH Consens. State. Sci. Statements 19: 1-26. *

• Noack KB, Speer T 1997 Investigation of the patient with abnormal liver function tests. Baillieres Clin. Gastroenterol. 11: 83-95.

• O'Brien S, Keogan M, Casey M, Duffy G, McErlean D, Fitzgerald MX, Hegarty JE 1992 Biliary complications of cystic fibrosis. Gut 33: 387-391. *

• O'Brien SM, Hatfield AR, Craig PI, Williams SP 1998 A 5-year follow-up of self-expanding metal stents in the endoscopic management of patients with benign bile duct strictures. Eur. J. Gastroenterol. Hepatol. 10: 141-145.

• O'Mahony CA, Vierling JM 2006 Etiopathogenesis of primary sclerosing cholangitis. Semin. Liver Dis. 26: 3-21. *

• Oikarinen H 2001 Imaging of biliary carcinoma, fistula and primary sclerosing cholangitis and percutaneous metallic stenting in malignant biliary obstruction. Department of Diagnostic Radiology, University of Oulu, Oulu Finland ISBN 951-42-5917-3 (http://herkules.oulu.fi/isbn9514259173/isbn9514259173.pdf). *

• Orth T, Neurath M, Schirmacher P, Galle PR, Mayet WJ 2000 A novel rat model of chronic fibrosing cholangitis induced by local administration of a hapten reagent into the dilated bile duct is associated with increased TNF-alpha production and autoantibodies. J. Hepatol. 33: 862-872. *

• Ozaslan E, Bayraktar Y 2002 Endoscopic therapy in the management of hepatobiliary hydatid disease. J. Clin. Gastroenterol. 35: 160-174.

• Pacholczyk M, Lagiewska B, Gontarczyk GW, Adadynski L, Chmura A, Wasiak D, Samsel R, Malanowski P, Perkowska-Ptasinska A, Rowinski W 2006 Biliary complications following liver transplantation: single-center experience. Transplant. Proc. 38: 247-249. *

• Panes J, Bordas JM, Bruguera M, Cortes M, Rodes J 1985 Localized sclerosing cholangitis? Endoscopy 17: 121-122.

• Papachristou GI, Demetris AJ, Craig F, Lee KKW, Rabinovitz M 2004 Cholestatic jaundice and bone lesions in an elderly woman. Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 53-57. *

• Papachristou GI, Wu T, Marsh W, Plevy SE 2004 Inflammatory pseudotumor of the liver associated with Crohn's disease. J. Clin. Gastroenterol. 38: 818-822.

• Park DH, Kim MH, Kim TN, Son HY, Lee TY, Kwon S, Oh HC, Lee SS, Seo DW, Lee SK 2007 Endoscopic treatment for suprapancreatic biliary stricture following blunt abdominal trauma. Am. J. Gastroenterol. 102: 544-549. *

• Park MS, Kim KW, Yu JS, Kim MJ, Kim KW, Lim JS, Cho ES, Yoon DS, Kim TK, Lee SI, Lee JD, Lee WJ, Ha HK, Lee JT, Yoo HS 2004 Early biliary complications of laparoscopic cholecystectomy: evaluation on T2-weighted MR cholangiography in conjunction with mangafodipir trisodium-enhanced 3D T1-weighted MR cholangiography. AJR Am. J. Roentgenol. 183: 1559-1566. *

• Park MS, Kim TK, Kim KW, Park SW, Lee JK, Kim JS, Lee JH, Kim KA, Kim AY, Kim PN, Lee MG, Ha HK 2004 Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology 233: 234-240. *

• Parlak E, Kuran SO, Disibeyaz S, Cicek B, Oguz D, Sahin B 2004 Endoscopic treatment of primary sclerosing cholangitis. Turk. J. Gastroenterol. 15: 144-148. *

• Patel T 2003 Aberrant local renin-angiotensin II responses in the pathogenesis of primary sclerosing cholangitis. Med. Hypotheses 61: 64-67. *

• Patel T, Singh P 2007 Cholangiocarcinoma: emerging approaches to a challenging cancer. Curr. Opin. Gastroenterol. 23: 317-323.

• Patkowski W, Nyckowski P, Zieniewicz K, Pawlak J, Michalowicz B, Kotulski M, Smoter P, Grodzicki M, Skwarek A, Ziolkowski J, Oldakowska-Jedynak U, Niewczas M, Paczek L, Krawczyk M 2003 Biliary tract complications following liver transplantation. Transplant. Proc. 35: 2316-2317. *

• Phatak N, Kochman ML 2004 Biliary endoscopy. Curr. Opin. Gastroenterol. 20: 281-287.

• Pilleul F, Courbiere M, Henry L, Scoazec JY, Valette PJ 2004 Etiology of biliary stenosis at MR cholangiography: correlation with pathology findings. J. Radiol. 85: 25-30.

• Piraka C, Shah RJ, Awadallah NS, Langer DA, Chen YK 2007 Transpapillary cholangioscopy-directed lithotripsy in patients with difficult bile duct stones. Clin. Gastroenterol. Hepatol. 5: 1333-1338.

• Portincasa P, Vacca M, Moschetta A, Petruzzelli M, Palasciano G, van-Erpecum KJ, van-Berge-Henegouwen GP 2005 Primary sclerosing cholangitis: updates in diagnosis and therapy. World J. Gastroenterol. 11: 7-16. *

• Prall RT, Lindor KD, Wiesner RH, LaRusso NF 2000 Current therapies and clinical controversies in the management of primary sclerosing cholangitis. Curr. Gastroenterol. Rep. 2: 99-103.

• Pratt DS 2005 Cholestasis and cholestatic syndromes. Curr. Opin. Gastroenterol. 21: 270-274.

• Principe A, Ercolani G, Bassi F, Paolucci U, Raspadori A, Turi P, Beltempo P, Grazi GL, Cavallari A 2003 Diagnostic dilemmas in biliary strictures mimicking cholangiocarcinoma. Hepatogastroenterology 50: 1246-1249.

• Puspok A 2006 Influence of technical advancements on the management of biliary tract diseases. Wien. Med. Wochenschr. 156: 386-390.

• Quiroga S, Sebastia MC, Margarit C, Castells L, Boye R, Alvarez-Castells A 2001 Complications of orthotopic liver transplantation: spectrum of findings with helical CT. Radiographics 21: 1085-1102. *

• Raijman I 1999 The Wallstent for benign biliary obstruction. Gastrointest. Endosc. Clin. N. Am. 9: 521-531.

• Raj V, Lichtenstein DR 1999 Hepatobiliary manifestations of inflammatory bowel disease. Gastroenterol. Clin. North Am. 28: 491-513.

• Rajwal SR, Davison SM, Prasad R, Brownlee K, McClean P 2007 Successful liver retransplantation for recurrent hepatopulmonary syndrome. Pediatr. Transplant. 11: 927-930.

• Rauws EA, Kloek JJ, Gouma DJ, Van Gulik TM 2008 Staging of cholangiocarcinoma: the role of endoscopy. HPB (Oxford) 10: 110-112. *

• Rehman SU, Amin MF, Hussain MA 2005 Management of HILAR malignant biliary strictures. J. Pak. Med. Assoc. 55: 339-342.

• Reichel C, Meier-Abt PJ 1997 Cholestatic liver diseases. Ther. Umsch. 54: 639-644.

• Rerknimitr R, Fogel EL, Kalayci C, Esber E, Lehman GA, Sherman S 2002 Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. Gastrointest. Endosc. 56: 885-889.

• Rizk RS, McVicar JP, Emond MJ, Rohrmann CA Jr, Kowdley KV, Perkins J, Carithers RL Jr, Kimmey MB 1998 Endoscopic management of biliary strictures in liver transplant recipients: effect on patient and graft survival. Gastrointest. Endosc. 47: 128-135. *

• Rodriguez HJ, Bass NM 2003 Primary sclerosing cholangitis. Semin. Gastrointest. Dis. 14: 189-198.

• Rosch T, Kyrein A, Zillinger C, Classen M 1999 Metal stents in gastroenterology. Chirurg. 70: 868-875.

• Rosmorduc O, Hermelin B, Boelle PY, Poupon RE, Poupon R, Chazouilleres O 2004 ABCB4 gene mutations and primary sclerosing cholangitis. Gastroenterology 126: 1220-1222. *

• Rumalla A, Baron TH, Leontovich O, Burgart LJ, Yacavone RF, Therneau TM, de Groen PC, Sebo TJ 2001 Improved diagnostic yield of endoscopic biliary brush cytology by digital image analysis. Mayo Clin. Proc. 76: 29-33. *

• Russo MW, Brown RS Jr 2003 Ethical issues in living donor liver transplantation. Curr. Gastroenterol. Rep. 5: 26-30.

• Saad WE, Saad NE, Davies MG, Lee DE, Patel NC, Sahler LG, Kitanosono T, Sasson T, Waldman DL 2005 Transhepatic balloon dilation of anastomotic biliary strictures in liver transplant recipients: the significance of a patent hepatic artery. J. Vasc. Interv. Radiol. 16: 1221-1228.

• Sahani DV, Kalva SP, Farrell J, Maher MM, Saini S, Mueller PR, Lauwers GY, Fernandez CD, Warshaw AL, Simeone JF 2004 Autoimmune pancreatitis: imaging features. Radiology 233: 345-352. *

• Salvalaggio PR, Bambini DA, Donaldson J, Saker M, Whitington PF, Alonso EM, Superina RA 2004 Simultaneous surgical and interventional radiological approach to treat complicated biliary strictures after pediatric liver transplantation. Pediatr. Transplant. 8: 513-516. *

• Sandhu BS, Luketic VA 2006 Management of primary sclerosing cholangitis. Gastroenterology & Hepatology 2: 843-849. *

• Sandrasegaran K, Alazmi WM, Tann M, Fogel EL, McHenry L, Lehman GA 2006 Chemotherapy-induced sclerosing cholangitis. Clin. Radiol. 61: 670-678. *

• Scheppach W, Druge G, Wittenberg G, Mueller JG, Gassel AM, Gassel HJ, Richter F 2001 Sclerosing cholangitis and liver cirrhosis after extrabiliary infections: report on three cases. Crit. Care Med. 29: 438-441.

• Schreuder TC, Hubscher SG, Neuberger J 2008 Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far? Transpl. Int. Jul 24 [Epub ahead of print]. *

• Schrumpf E, Boberg KM 2002 Endoscopic treatment for primary sclerosing cholangitis? J. Hepatol. 36: 278-279. *

• Schweizer W, Schott G, Zimmermann A, Triller J, Blumgart LH 1993 Clinical significance and histological classification of atrophy/hypertrophy complexes of the liver. Schweiz. Med. Wochenschr. 123: 1598-1603.

• Sciume C, Geraci G, Pisello F, Facella T, Li Volsi F, Modica G 2004 Prevention of clogging of biliary stents by administration of levofloxacin and ursodeoxycholic acid. Chir. Ital. 56: 831-837.

• Sebagh M, Farges O, Kalil A, Samuel D, Bismuth H, Reynes M 1995 Sclerosing cholangitis following human orthotopic liver transplantation. Am. J. Surg. Pathol. 19: 81-90.

• Sewkani A, Kapoor S, Sharma S, Naik S, Debbarma MK, Varshney S 2005 IgG4 negative sclerosing cholangitis associated with autoimmune pancreatitis. JOP 6: 269-273. *

• Shah JN, Ahmad NA, Shetty K, Kochman ML, Long WB, Brensinger CM, Pfau PR, Olthoff K, Markmann J, Shaked A, Reddy KR, Ginsberg GG 2004 Endoscopic management of biliary complications after adult living donor liver transplantation. Am. J. Gastroenterol. 99: 1291-1295. *

• Shah RJ, Langer DA, Antillon MR, Chen YK 2006 Cholangioscopy and cholangioscopic forceps biopsy in patients with indeterminate pancreaticobiliary pathology. Clin. Gastroenterol. Hepatol. 4: 219-225.

• Shah SA, Grant DR, McGilvray ID, Greig PD, Selzner M, Lilly LB, Girgrah N, Levy GA, Cattral MS 2007 Biliary strictures in 130 consecutive right lobe living donor liver transplant recipients: results of a Western center. Am. J. Transplant. 7: 161-167. *

• Sheng R, Campbell WL, Zajko AB, Baron RL 1996 Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: evidence of recurrent disease. AJR Am. J. Roentgenol. 166: 1109-1113. *

• Sheng R, Zajko AB, Campbell WL, Abu-Elmagd K 1993 Biliary strictures in hepatic transplants: prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases. AJR Am. J. Roentgenol. 161: 297-300. *

• Shin YS, Jang YS, Kang MK, Jang BK, Park KS, Hwang JS, Kwon JH, Kang YN 2007 A case of sclerosing cholangitis showing response to prednisolone. Korean J. Gastroenterol. 50: 402-406.

• Shio S, Yazumi S, Ogawa K, Hasegawa K, Tsuji Y, Kida M, Yamauchi J, Ida H, Tada S, Uemoto S, Chiba T 2008 Biliary complications in donors for living donor liver transplantation. Am. J. Gastroenterol. 103: 1393-1398. *

• Shirokova EN 2006 Diagnosis and differential diagnosis of primary sclerosing cholangitis. Falk Workshop "Primary Sclerosing Cholangitis: Complications and Consequences", Moscow (Russia), June 11, 2006, p. 8. *

• Silveira MG, Lindor KD 2008 Primary sclerosing cholangitis. Can. J. Gastroenterol. 22: 689-698. *

• Simmons TC 1991 Distal common bile duct stricture and secondary biliary cirrhosis due to choledocholithiasis. J. Natl. Med. Assoc. 83: 1105-1108.

• Small AJ, Baron TH 2008 Novel endoscopic approaches for assessing biliary tract diseases. Curr. Opin. Gastroenterol. 24: 357-362.

• Song Y, Liu QD, Zhou NX, Zhang WZ, Wang DJ 2008 Diagnosis and management of autoimmune pancreatitis: experience from China. World J. Gastroenterol. 14: 601-606. *

• Springer DJ, Gaing AA, Siegel JH 1993 Radiologic regression of primary sclerosing cholangitis following combination therapy with an endoprosthesis and ursodeoxycholic acid. Am. J. Gastroenterol. 88: 1957-1959.

• St Peter S, Rodriquez-Davalos MI, Rodriguez-Luna HM, Harrison EM, Moss AA, Mulligan DC 2004 Significance of proximal biliary dilatation in patients with anastomotic strictures after liver transplantation. Dig. Dis. Sci. 49: 1207-1211. *

• Steele IL, Levy C, Lindor KD 2007 Primary sclerosing cholangitis - approach to diagnosis. MedGenMed. 9: 20.

• Stelzmueller I, Berger N, Wiesmayr S, Eller M, Tabarelli W, Fille M, Margreiter R, Bonatti H 2007 Group milleri streptococci: significant pathogens in solid organ recipients. Transpl. Int. 20: 51-56. *

• Stewart CJ, Mills PR, Carter R, O'Donohue J, Fullarton G, Imrie CW, Murray WR 2001 Brush cytology in the assessment of pancreatico-biliary strictures: a review of 406 cases. J. Clin. Pathol. 54: 449-455. *

• Stiehl A 2003 Endoscopic interventions in the biliary tract. Curr. Treat. Options Gastroenterol. 6: 87-92.

• Stiehl A 2002 Primary sclerosing cholangitis: neoplastic potential in bile ducts, colon and the pancreas? J. Hepatol. 36: 433-434. *

• Sung J 2004 Are covered stents superior to uncovered stents in the management of malignant biliary obstruction? Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 20-21. *

• Sutcliffe R, Maguire D, Mroz A, Portmann B, O'Grady J, Bowles M, Muiesan P, Rela M, Heaton N 2004 Bile duct strictures after adult liver transplantation: a role for biliary reconstructive surgery? Liver Transpl. 10: 928-934. *

• Tashiro H, Itamoto T, Sasaki T, Ohdan H, Fudaba Y, Amano H, Fukuda S, Nakahara H, Ishiyama K, Ohshita A, Kohashi T, Mitsuta H, Chayama K, Asahara T 2007 Biliary complications after duct-to-duct biliary reconstruction in living-donor liver transplantation: causes and treatment. World J. Surg. 31: 2222-2229. *

• Tashiro H, Ogawa T, Itamoto T, Ushitora Y, Tanimoto Y, Oshita A, Amano H, Asahara T 2008 Synthetic bioabsorbable stent material for duct-to-duct biliary reconstruction. J. Surg. Res. Apr 3 [Epub ahead of print].

• Taylor CJ, Kong J, Ghusn M, White S, Crampton N, Layani L 2007 Laparoscopic bile duct exploration: results of 160 consecutive cases with 2-year follow up. ANZ J. Surg. 77: 440-445. *

• Te HS, Baker AL 1999 Intrahepatic cholestasis following liver transplantation. Clin. Liver Dis. 3: 633-649.

• ter Borg PC, van Buuren HR, Depla AC 2002 Bacterial cholangitis causing secondary sclerosing cholangitis: a case report. BMC Gastroenterol. 2: 14. *

• Theilmann L, Kuppers B, Kadmon M, Roeren T, Notheisen H, Stiehl A, Otto G 1994 Biliary tract strictures after orthotopic liver transplantation: diagnosis and management. Endoscopy 26: 517-522.

• Thethy S, Thomson BNj, Pleass H, Wigmore SJ, Madhavan K, Akyol M, Forsythe JL, James Garden O 2004 Management of biliary tract complications after orthotopic liver transplantation. Clin. Transplant. 18: 647-653. *

• Thimme R, Opitz OG, Blum HE, Kreisel W 2004 Cholestatic liver diseases. Ther. Umsch. 61: 521-527.

• Thuluvath PJ, Pfau PR, Kimmey MB, Ginsberg GG 2005 Biliary complications after liver transplantation: the role of endoscopy. Endoscopy 37: 857-863.

• Tischendorf JJ, Meier PN, Schneider A, Manns MP, Kruger M 2007 Transpapillary intraductal ultrasound in the evaluation of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Scand. J. Gastroenterol. 42: 1011-1017. *

• Toosi MN, Heathcote J 2004 Pancreatic pseudotumor with sclerosing pancreato-cholangitis: is this a systemic disease? Am. J. Gastroenterol. 99: 377-382. *

• Topazian M, Witzig TE, Smyrk TC, Pulido JS, Levy MJ, Kamath PS, Chari ST 2008 Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin. Gastroenterol. Hepatol. 6: 364-366.

• Torok N, Gores GJ 2001 Cholangiocarcinoma. Semin. Gastrointest. Dis. 12: 125-132.

• Tritto G, Iaccarino V, De Martino S, D'Agostino L 2000 A case of sclerosing cholangitis managed by a percutaneous approach. J. Clin. Gastroenterol. 30: 205-209.

• Tsujino T, Isayama H, Sugawara Y, Sasaki T, Kogure H, Nakai Y, Yamamoto N, Sasahira N, Yamashiki N, Tada M, Yoshida H, Kokudo N, Kawabe T, Makuuchi M, Omata M 2006 Endoscopic management of biliary complications after adult living donor liver transplantation. Am. J. Gastroenterol. 101: 2230-2236. *

• Tsukamoto T, Hirohashi K, Kubo S, Tanaka H, Hamba H, Shuto T, Takemura S, Kinoshita H 2004 Self-expanding metallic stent for benign biliary strictures: seven-year follow-up. Hepatogastroenterology 51: 658-660.

• Twaddell WS, Lefkowitch J, Berk PD 2008 Evolution from primary biliary cirrhosis to primary biliary cirrhosis/autoimmune hepatitis overlap syndrome. Semin. Liver Dis. 28: 128-134.

• Ueda M, Nakamura T, Tohyama T, Kushihata F, Honda Y, Kobayashi N 2003 Advanced cholangiocarcinoma in a patient with stage I primary sclerosing cholangitis. J. Hepatobiliary Pancreat. Surg. 10: 245-249.

• Van Beers BE 2008 Diagnosis of cholangiocarcinoma. HPB (Oxford) 10: 87-93. *

• van Brummelen SE, Venneman NG, van Erpecum KJ, VanBerge-Henegouwen GP 2003 Acute idiopathic pancreatitis: does it really exist or is it a myth? Scand. J. Gastroenterol. Suppl. 239: 117-122. *

• Van Buuren HR, Vleggaar FP, Willemien Erkelens G, Zondervan PE, Lesterhuis W, Van Eijck CH, Puylaert JB, Van Der Werf SD 2006 Autoimmune pancreatocholangitis: a series of ten patients. Scand. J. Gastroenterol. Suppl. 243: 70-78. *

• van den Hazel SJ, Speelman P, Dankert J, Huibregtse K, Tytgat GN, van Leeuwen DJ. 1996 Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography. A randomized, controlled trial. Ann. Intern. Med. 125: 442-447.

• Van Laethem JL, Adler M, Bougeois N, Deprez C, Ryckaert F, Zalcman M, Gelin M, Cremer M 1991 Primary sclerosing cholangitis: contribution of retrograde cholangiography in follow-up: apropos of 15 case reports. Acta Gastroenterol. Belg. 54: 305-314.

• van Milligen de Wit AW, van Bracht J, Rauws EA, Jones EA, Tytgat GN, Huibregtse K 1996 Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis. Gastrointest. Endosc. 44: 293-299.

• van Milligen de Wit AW, van Deventer SJ, Tytgat GN 1995 Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies. Am. J. Gastroenterol. 90: 893-900.

• Varadarajulu S, Eloubeidi MA, Wilcox CM 2007 Prospective evaluation of indeterminate ERCP findings by intraductal ultrasound. J. Gastroenterol. Hepatol. 22: 2086-2092. *

• Verdonk RC, Buis CI, Porte RJ, Haagsma EB 2006 Biliary complications after liver transplantation: a review. Scand. J. Gastroenterol. Suppl. 243: 89-101. *

• Vitellas KJ, Guttikonda S 2002 Hepatic transplant complicated by hepatic artery thrombosis and bile duct necrosis: case report and potential application of contrast-enhanced MR cholangiography following intravenous mangafodipir trisodium in the emergency room setting. Emerg. Radiol. 9: 106-109.

• Vitellas KM, Keogan MT, Spritzer CE, Nelson RC 2000 MR cholangiopancreatography of bile and pancreatic duct abnormalities with emphasis on the single-shot fast spin-echo technique. Radiographics 20: 939-957. *

• Vleggaar FP, Van Ooteghem NA, Van Buuren HR, Van Berge Henegouwen GP 2000 Cholestatic liver diseases: slow progress in understanding and treating slowly progressive disorders. Scand. J. Gastroenterol. Suppl. 232: 86-92.

• Vogel SB, Howard RJ, Caridi J, Hawkins IF Jr 1985 Evaluation of percutaneous transhepatic balloon dilatation of benign biliary strictures in high-risk patients. Am. J. Surg. 149: 73-79.

• Wagner S, Gebel M, Meier P, Trautwein C, Bleck J, Nashan B, Manns MP 1996 Endoscopic management of biliary tract strictures in primary sclerosing cholangitis. Endoscopy 28: 546-551.

• Wakabayashi H, Akamoto S, Yachida S, Okano K, Izuishi K, Nishiyama Y, Maeta H 2005 Significance of fluorodeoxyglucose PET imaging in the diagnosis of malignancies in patients with biliary stricture. Eur. J. Surg. Oncol. 31: 1175-1179.

• Walker JG, Young WB, George P, Sherlock S 1966 Percutaneous cholangiography in the management of biliary stricture. Gut 7: 164-174. *

• Wallick K, Dickinson M, James DS, Kugelmas M, Madinger N, Rodman D 2002 Chronic mucoid Pseudomonas aeruginosa cholangitis complicating ERCP in a CF patient. J. Cyst. Fibros. 1: 99-101.

• Wamsteker EJ 2007 Updates in biliary endoscopy 2006. Curr. Opin. Gastroenterol. 23: 324-328.

• Wamsteker EJ 2006 Updates in biliary endoscopy. Curr. Opin. Gastroenterol. 22: 300-304.

• Wamsteker EJ, Anderson MA 2004 Fluorescence in situ hybridization for the detection of malignant bile duct strictures: has FISH found a new pond? Am. J. Gastroenterol. 99: 1682-1683. *

• Warshaw AL, Schapiro RH, Ferrucci JT Jr, Galdabini JJ 1976 Persistent obstructive jaundice, cholangitis, and biliary cirrhosis due to common bile duct stenosis in chronic pancreatitis. Gastroenterology 70: 562-567.

• Wasan SM, Ross WA, Staerkel GA, Lee JH 2005 Use of expandable metallic biliary stents in resectable pancreatic cancer. Am. J. Gastroenterol. 100: 2056-2061. *

• Washington K 2005 Update on post-liver transplantation infections, malignancies, and surgical complications. Adv. Anat. Pathol. 12: 221-226.

• Waters DL, Dorney SF, Gruca MA, Martin HC, Howman-Giles R, Kan AE, De Silva M, Gaskin KJ 1995 Hepatobiliary disease in cystic fibrosis patients with pancreatic sufficiency. Hepatology 21: 963-969.

• Welsh FK, Wigmore SJ 2004 Roux-en-Y choledochojejunostomy is the method of choice for biliary reconstruction in liver transplantation for primary sclerosing cholangitis. Transplantation 77: 602-604.

• White TT, Hart MJ 1987 Primary sclerosing cholangitis. Am. J. Surg. 153: 439-443.

• Wiesner RH, Porayko MK, Hay JE, LaRusso NF, Steers JL, Krom RA, Dickson ER 1996 Liver transplantation for primary sclerosing cholangitis: impact of risk factors on outcome. Liver Transpl. Surg. 2: 99-108.

• Willett IR, McCutcheon AD, Dudley FJ 1985 Endoscopic balloon dilatation of biliary strictures. Med. J. Aust. 143: 208-210.

• Wojtun S, Gil J, Zysko B 2007 The use of endoscopic method in treatment of strictures of biliary tree. Pol. Merkur. Lekarski. 22: 477-481.

• Worley P, Roberts-Thomson I, Dymock R, Maddern G 2001 Benign inflammatory pseudotumour of the biliary tract masquerading as a Klatskin tumour. HPB (Oxford) 3: 179-181. *

• Yamagiwa S, Ichida T 2007 Recurrence of primary biliary cirrhosis and primary sclerosing cholangitis after liver transplantation in Japan. Hepatol. Res. 37 Suppl. 3: S449-S454. *

• Yamamoto S, Sato Y, Oya H, Nakatsuka H, Kobayashi T, Hara Y, Watanabe T, Kurosaki I, Hatakeyama K 2007 Risk factors and prevention of biliary anastomotic complications in adult living donor liver transplantation. World J. Gastroenterol. 13: 4236-4241. *

• Yazumi S, Chiba T 2005 Biliary complications after a right-lobe living donor liver transplantation. J. Gastroenterol. 40: 861-865. *

• Yoon JH, Gores GJ 2003 Diagnosis, staging, and treatment of cholangiocarcinoma. Curr. Treat. Options Gastroenterol. 6: 105-112.

• Yska MJ, Buis CI, Monbaliu D, Schuurs TA, Gouw AS, Kahmann ON, Visser DS, Pirenne J, Porte RJ 2008 The role of bile salt toxicity in the pathogenesis of bile duct injury after non-heart-beating porcine liver transplantation. Transplantation 85: 1625-1631.

• Yusuf TE, Baron TH 2004 AIDS cholangiopathy. Curr. Treat. Options Gastroenterol. 7: 111-117.

• Zetterman RK 2003 Clinical topics in liver disease. American College of Gastroenterology 68th Annual Scientific Meeting and Postgraduate Course, October 10 - 15, 2003, Baltimore, Maryland.

• Zoepf T, Maldonado-Lopez EJ, Hilgard P, Dechene A, Malago M, Broelsch CE, Schlaak J, Gerken G 2005 Diagnosis of biliary strictures after liver transplantation: which is the best tool? World J. Gastroenterol. 11: 2945-2948. *

Number of references = 392

www psc-literature.org